Tags

Type your tag names separated by a space and hit enter

The Effect of a New Angiographic Imaging Technology on Radiation Dose in Visceral Embolization Procedures.
Vasc Endovascular Surg 2017; 51(4):183-187VE

Abstract

PURPOSE

To evaluate the impact of a new angiographic imaging technology on radiation dose during visceral embolization procedures involving both fluoroscopy and digital subtraction angiography.

MATERIAL AND METHODS

A retrospective analysis from a single-center consecutive series of patients was performed comparing 2 angiographic imaging systems. The AlluraClarity (CIQ; Philips Healthcare, Best, the Netherlands) was used in 100 patients (n = 59 male, mean age: 70.6 years) from July 2013 to April 2014 and compared to the former AlluraXper (AX) technology used in 139 patients (n = 71 male, mean age: 70.1 years) from May 2011 to June 2013. Patients were categorized according to body mass index (BMI [kg/m2])-group 1: BMI <25, group 2: BMI ≥25 and <30, and group 3: BMI ≥30. Fluoroscopy time, the total dose of iodinated contrast administered, and procedural AirKerma (Ka, r [mGy]) were obtained.

RESULTS

Mean BMI was 26.4 ± 5.0 kg/m2 in the CIQ and 26.4 ± 7.1 kg/m2 in the AX group (P = .93). Fluoroscopy time and the amount of contrast media were equally distributed. Ka, r was 1342.9 mGy versus 2214.8 mGy (P < .001, t test) when comparing CIQ to AX. Comparing CIQ to AX, BMI subgroup analysis revealed a mean Ka, r of 970.1 to 1586.1 mGy (P = .003, t test), 1484.7 to 2170.1 mGy (P = .02, t test), and 1848.8 to 3348.9 mGy (P = .001, t test) in BMI groups 1, 2, and 3, respectively.

CONCLUSION

The CIQ technology significantly reduced mean radiation dose by 39.4% for visceral embolization procedures when compared to fluoroscopy time and contrast media dose. This dose relationship was consistent across all BMI groups.

Authors+Show Affiliations

1 Miami Cardiac & Vascular Institute, Baptist Hospital, Miami, FL, USA. 2 Clinical and Interventional Angiology, University Hospital of Zurich, Zurich, Switzerland.1 Miami Cardiac & Vascular Institute, Baptist Hospital, Miami, FL, USA.2 Clinical and Interventional Angiology, University Hospital of Zurich, Zurich, Switzerland. 3 Clinic for Interventional Radiology, University Hospital of Mainz, Mainz, Germany.1 Miami Cardiac & Vascular Institute, Baptist Hospital, Miami, FL, USA.1 Miami Cardiac & Vascular Institute, Baptist Hospital, Miami, FL, USA.1 Miami Cardiac & Vascular Institute, Baptist Hospital, Miami, FL, USA.

Pub Type(s)

Comparative Study
Evaluation Study
Journal Article

Language

eng

PubMed ID

28424042

Citation

Baumann, Frederic, et al. "The Effect of a New Angiographic Imaging Technology On Radiation Dose in Visceral Embolization Procedures." Vascular and Endovascular Surgery, vol. 51, no. 4, 2017, pp. 183-187.
Baumann F, Peña C, Kloeckner R, et al. The Effect of a New Angiographic Imaging Technology on Radiation Dose in Visceral Embolization Procedures. Vasc Endovascular Surg. 2017;51(4):183-187.
Baumann, F., Peña, C., Kloeckner, R., Katzen, B. T., Gandhi, R., & Benenati, J. B. (2017). The Effect of a New Angiographic Imaging Technology on Radiation Dose in Visceral Embolization Procedures. Vascular and Endovascular Surgery, 51(4), pp. 183-187. doi:10.1177/1538574417698903.
Baumann F, et al. The Effect of a New Angiographic Imaging Technology On Radiation Dose in Visceral Embolization Procedures. Vasc Endovascular Surg. 2017;51(4):183-187. PubMed PMID: 28424042.
* Article titles in AMA citation format should be in sentence-case
TY - JOUR T1 - The Effect of a New Angiographic Imaging Technology on Radiation Dose in Visceral Embolization Procedures. AU - Baumann,Frederic, AU - Peña,Constantino, AU - Kloeckner,Roman, AU - Katzen,Barry T, AU - Gandhi,Ripal, AU - Benenati,James B, Y1 - 2017/03/20/ PY - 2017/4/21/entrez PY - 2017/4/21/pubmed PY - 2017/8/2/medline KW - imaging technology KW - radiation reduction KW - visceral embolization SP - 183 EP - 187 JF - Vascular and endovascular surgery JO - Vasc Endovascular Surg VL - 51 IS - 4 N2 - PURPOSE: To evaluate the impact of a new angiographic imaging technology on radiation dose during visceral embolization procedures involving both fluoroscopy and digital subtraction angiography. MATERIAL AND METHODS: A retrospective analysis from a single-center consecutive series of patients was performed comparing 2 angiographic imaging systems. The AlluraClarity (CIQ; Philips Healthcare, Best, the Netherlands) was used in 100 patients (n = 59 male, mean age: 70.6 years) from July 2013 to April 2014 and compared to the former AlluraXper (AX) technology used in 139 patients (n = 71 male, mean age: 70.1 years) from May 2011 to June 2013. Patients were categorized according to body mass index (BMI [kg/m2])-group 1: BMI <25, group 2: BMI ≥25 and <30, and group 3: BMI ≥30. Fluoroscopy time, the total dose of iodinated contrast administered, and procedural AirKerma (Ka, r [mGy]) were obtained. RESULTS: Mean BMI was 26.4 ± 5.0 kg/m2 in the CIQ and 26.4 ± 7.1 kg/m2 in the AX group (P = .93). Fluoroscopy time and the amount of contrast media were equally distributed. Ka, r was 1342.9 mGy versus 2214.8 mGy (P < .001, t test) when comparing CIQ to AX. Comparing CIQ to AX, BMI subgroup analysis revealed a mean Ka, r of 970.1 to 1586.1 mGy (P = .003, t test), 1484.7 to 2170.1 mGy (P = .02, t test), and 1848.8 to 3348.9 mGy (P = .001, t test) in BMI groups 1, 2, and 3, respectively. CONCLUSION: The CIQ technology significantly reduced mean radiation dose by 39.4% for visceral embolization procedures when compared to fluoroscopy time and contrast media dose. This dose relationship was consistent across all BMI groups. SN - 1938-9116 UR - https://www.unboundmedicine.com/medline/citation/28424042/The_Effect_of_a_New_Angiographic_Imaging_Technology_on_Radiation_Dose_in_Visceral_Embolization_Procedures_ L2 - http://journals.sagepub.com/doi/full/10.1177/1538574417698903?url_ver=Z39.88-2003&amp;rfr_id=ori:rid:crossref.org&amp;rfr_dat=cr_pub=pubmed DB - PRIME DP - Unbound Medicine ER -